Literature DB >> 23251727

The holistic perspective of chronic obstructive pulmonary disease: doubt some more.

Jaymin B Morjaria1, Riccardo Polosa.   

Abstract

Entities:  

Year:  2010        PMID： 23251727      PMCID： PMC3513856          DOI： 10.1177/2040622310373959

Source DB:  PubMed          Journal:  Ther Adv Chronic Dis        ISSN： 2040-6223            Impact factor:   5.091


× No keyword cloud information.
  30 in total

1.  Effect of smoking cessation on mortality after myocardial infarction: meta-analysis of cohort studies.

Authors:  K Wilson; N Gibson; A Willan; D Cook
Journal:  Arch Intern Med       Date:  2000-04-10

Review 2.  Acute effects of cigarette smoke on inflammation and oxidative stress: a review.

Authors:  H van der Vaart; D S Postma; W Timens; N H T ten Hacken
Journal:  Thorax       Date:  2004-08       Impact factor: 9.139

3.  C-reactive protein and mortality in mild to moderate chronic obstructive pulmonary disease.

Authors:  S F P Man; J E Connett; N R Anthonisen; R A Wise; D P Tashkin; D D Sin
Journal:  Thorax       Date:  2006-05-31       Impact factor: 9.139

4.  Short-term economic and health benefits of smoking cessation: myocardial infarction and stroke.

Authors:  J M Lightwood; S A Glantz
Journal:  Circulation       Date:  1997-08-19       Impact factor: 29.690

5.  Effect of 1-year smoking cessation on airway inflammation in COPD and asymptomatic smokers.

Authors:  B W M Willemse; N H T ten Hacken; B Rutgers; I G A T Lesman-Leegte; D S Postma; W Timens
Journal:  Eur Respir J       Date:  2005-11       Impact factor: 16.671

6.  Salmeterol and fluticasone propionate and survival in chronic obstructive pulmonary disease.

Authors:  Peter M A Calverley; Julie A Anderson; Bartolome Celli; Gary T Ferguson; Christine Jenkins; Paul W Jones; Julie C Yates; Jørgen Vestbo
Journal:  N Engl J Med       Date:  2007-02-22       Impact factor: 91.245

7.  The relationship between chronic hypoxemia and activation of the tumor necrosis factor-alpha system in patients with chronic obstructive pulmonary disease.

Authors:  N Takabatake; H Nakamura; S Abe; S Inoue; T Hino; H Saito; H Yuki; S Kato; H Tomoike
Journal:  Am J Respir Crit Care Med       Date:  2000-04       Impact factor: 21.405

8.  Association of bronchial hyperresponsiveness and lung function with C-reactive protein (CRP): a population based study.

Authors:  S Kony; M Zureik; F Driss; C Neukirch; B Leynaert; F Neukirch
Journal:  Thorax       Date:  2004-10       Impact factor: 9.139

9.  Effect of potentially modifiable risk factors associated with myocardial infarction in 52 countries (the INTERHEART study): case-control study.

Authors:  Salim Yusuf; Steven Hawken; Stephanie Ounpuu; Tony Dans; Alvaro Avezum; Fernando Lanas; Matthew McQueen; Andrzej Budaj; Prem Pais; John Varigos; Liu Lisheng
Journal:  Lancet       Date:  2004 Sep 11-17       Impact factor: 79.321

Review 10.  C-reactive protein and cardiovascular disease: weighing the evidence.

Authors:  Gordon D O Lowe; Mark B Pepys
Journal:  Curr Atheroscler Rep       Date:  2006-09       Impact factor: 5.113
View more
  2 in total

1.  Health effects in COPD smokers who switch to electronic cigarettes: a retrospective-prospective 3-year follow-up.

Authors:  Riccardo Polosa; Jaymin Bhagwanji Morjaria; Umberto Prosperini; Cristina Russo; Alfio Pennisi; Rosario Puleo; Massimo Caruso; Pasquale Caponnetto
Journal:  Int J Chron Obstruct Pulmon Dis       Date:  2018-08-22

2.  Chronic Obstructive Pulmonary Disease Symptom Cluster Composition, Associated Factors, and Methodologies: A Systematic Review.

Authors:  Fei Fei; Jonathan Koffman; Xiaohan Zhang; Wei Gao
Journal:  West J Nurs Res       Date:  2021-03-06       Impact factor: 1.967
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.